Meeting
2022 ASCO Annual Meeting
Whole transcriptome analysis of tumors with discordant oncotype and MammaPrint results in the FLEX trial.
Authors
Matei P. Socoteanu
Texas Oncology-Longview Cancer Center, US Oncology, Longview, TX
Matei P. Socoteanu , Joyce O'Shaughnessy , Kent Hoskins , Adam Brufsky , Cathy Lynne Graham , Svetislava J. Vukelja , Jamal Ghazi Misleh , Karen L. Tedesco , Rakhshanda Layeequr Rahman , June Lee , Julian Berrocal , Kamal Sharma , Albert Begas , Jennifer Crozier , Ian Grady , Nina D'Abreo , Midas M. Kuilman , Holly Nguyen , Lisa Eileen Blumencranz , M. William Audeh
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Biologic Correlates
Clinical Trial Registration Number
NCT03053193
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 556)
DOI
10.1200/JCO.2022.40.16_suppl.556
Abstract #
556
Poster Bd #
328
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Defining transcriptomic profiles of early-stage mucinous breast cancers: A FLEX sub study.
First Author: Abirami Sivapiragasam
Poster
2022 ASCO Annual Meeting
FLEX, the 30,000 breast cancer transcriptome project: A platform for early breast cancer research using full-genome arrays paired with clinical data.
First Author: Cynthia X. Ma
Poster
2022 ASCO Annual Meeting
Clinical implications for patients with discordant oncotype and MammaPrint results.
First Author: Matei P. Socoteanu
Poster
2021 ASCO Annual Meeting
Gene expression associated with lymphovascular invasion and genomic risk in early-stage breast cancer.
First Author: Nina D'Abreo